SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹26 Cr | ₹25 Cr | ₹15 Cr | ₹10 Cr | ₹9.67 Cr |
What is the latest Total Current Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹26 Cr |
Mar2023 | ₹25 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹10 Cr |
Mar2020 | ₹9.67 Cr |
How is Total Current Liabilities of SHREE GANESH REMEDIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹26 Cr | 3.22 | |
Mar2023 | ₹25 Cr | 67.19 | |
Mar2022 | ₹15 Cr | 47.62 | |
Mar2021 | ₹10 Cr | 5.37 | |
Mar2020 | ₹9.67 Cr | - |
Compare Total Current Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,039.4 Cr | 3.4% | 13.5% | 10.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 3.4% |
13.5% |
10.9% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses